Drug Side Effects
Search
VASCULAR HYALINOSIS
VASCULAR HYALINOSIS
was reported 85 times
VASCULAR HYALINOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Antimetabolite Immunosuppressant [EPC]
11
0.0005
1
Selective T Cell Costimulation Blocker [EPC]
2
0.0004
2
Glinide [EPC]
3
0.0003
3
Sulfone [EPC]
3
0.0003
4
Calcineurin Inhibitor Immunosuppressant [EPC]
15
0.0001
5
Central alpha-2 Adrenergic Agonist [EPC]
6
0.0001
6
B Lymphocyte Stimulator-specific Inhibitor [EPC]
3
0.0001
7
Lipid-based Polyene Antifungal [EPC]
1
0.0001
8
Vitamin D3 Analog [EPC]
1
0.0000
9
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
10
Interleukin-6 Receptor Antagonist [EPC]
6
0.0000
11
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
12
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
4
0.0000
13
Calcium [EPC]
6
0.0000
14
Androgen [EPC]
1
0.0000
15
Corticosteroid [EPC]
47
0.0000
16
Purine Antimetabolite [EPC]
3
0.0000
17
Kinase Inhibitor [EPC]
16
0.0000
18
CD20-directed Cytolytic Antibody [EPC]
8
0.0000
19
Polyene Antifungal [EPC]
1
0.0000
20
Expectorant [EPC]
5
0.0000
21
Complement Inhibitor [EPC]
1
0.0000
22
Dihydropyridine Calcium Channel Blocker [EPC]
4
0.0000
23
HMG-CoA Reductase Inhibitor [EPC]
4
0.0000
24
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1
0.0000
25
Loop Diuretic [EPC]
4
0.0000
26
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
27
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
28
Fluoroquinolone Antibacterial [EPC]
1
0.0000
29
Azole Antifungal [EPC]
1
0.0000
30
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
31
Platelet Aggregation Inhibitor [EPC]
3
0.0000
32
Nonsteroidal Anti-inflammatory Drug [EPC]
4
0.0000
33
Vitamin C [EPC]
1
0.0000
34
Proton Pump Inhibitor [EPC]
1
0.0000
35
Tumor Necrosis Factor Blocker [EPC]
1
0.0000